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Hyaluronan-binding protein 1 (HABP1)/p32/gC1qR
was characterized as a highly acidic and oligomeric pro-
tein, which binds to different ligands like hyaluronan,
C1q, and mannosylated albumin. It exists as trimer in
high ionic and reducing conditions as shown by crystal
structure. In the present study, we have examined the
structural changes of HABP1 under a wide range of
ionic environments. HABP1 exhibits structural plastic-
ity, which is influenced by the ionic environment under
in vitro conditions near physiological pH. At low ionic
strength HABP1 exists in a highly expanded and loosely
held trimeric structure, similar to that of the molten
globule-like state, whereas the presence of salt stabilizes
the trimeric structure in a more compact fashion. It is
likely that the combination of the high net charge asym-
metrically distributed along the faces of the molecule
and the relatively low intrinsic hydrophobicity of
HABP1 result in its expanded structure at neutral pH.
Thus, the addition of counter ions in the molecular en-
vironment minimizes the intramolecular electrostatic
repulsion in HABP1 leading to its stable and compact
conformations, which reflect in its differential binding
toward different ligands. Whereas the binding of HABP1
toward HA is enhanced on increasing the ionic strength,
no significant effect was observed with the two other
ligands, C1q and mannosylated albumin. Thus, although
HA interacts only with compact HABP1, C1q and man-
nosylated albumin can bind to loosely held oligomeric
HABP1 as well. In other words, structural changes in
HABP1 mediated by changes in the ionic environment
are responsible for recognizing different ligands.
The ubiquitous glycosaminoglycan hyaluronan is an un-
branched polysaccharide composed entirely of a repeating dis-
accharide, D-glucuronic acid (133) N-acetyl-D-glucosamine
(134), which, unlike other glycosaminoglycans, is neither
attached to a protein core nor O- or N-sulfated. It has diverse
biological roles in vertebrates; these include acting as a vital
structural component of connective tissues; the formation of
loose hydrated matrices that allow cells to divide and migrate
during development, immune cell adhesion, and activation;
and in intracellular signaling (1–5). This wide range of activi-
ties in fact results from its interactions with a large number of
proteins termed as hyaladherin that exhibit significant differ-
ences in their tissue expression, cellular localization, specific-
ity, affinity, and regulation (2).
Hyaluronan-binding protein 1 (HABP1)1 one of the members
of hyaladherin family, is originally purified as a novel receptor
of hyaluronan by our group (6–8). We established its role in cell
adhesion and tumor invasion (8–9) and sperm maturation and
motility (10, 11). The cDNA encoding hyaluronan-binding pro-
tein 1 has been cloned by immunoscreening the human skin
fibroblast expression library, sequenced, and overexpressed (7).
Sequence analysis confirmed that although HABP1 is synthe-
sized as pro-protein form of 282 amino acids, the first 73 NH2-
terminal residues are cleaved immediately to generate a ma-
ture form of HABP1. The presence of an HA-binding motif has
been confirmed, and subsequently the recombinant protein has
been shown to bind HA. The multifunctional nature of HABP1
is revealed due to its sequence identity with p32, a protein
co-purified with splicing factor SF2 (12) and with the receptor
of globular head of complement factor 1q (gC1qR) (13) and is
represented as synonyms of C1QBP, gC1qR, and p32 (Gen-
BankTM accession number NP_001203). Many homologous and
identical genes of this molecule have been identified in eukary-
otic species, ranging from fungi to mammals from sequence
analysis data as well as biochemical studies (14). This protein
is reported by several investigators (15–16) to be present in
cytosol, mitochondria, and cell surface in different cell types.
Even its presence in the nucleus of virally transformed cell
lines is demonstrated. This is probably explained as the role of
HABP1 in cellular signaling is well documented and has been
strengthened by our recent observations that being an endog-
enous substrate of ERK1/ERK2, it translocated to nucleus upon
phosphorylation (17).
The crystal structure of HABP1 showed that it exists as a
homotrimer, and each protomer consists of seven consecutive
twisted anti-parallel -sheets flanked by one NH2-terminal and
two COOH-terminal -helices and that the terminal -helices
have extensive intra- as well as intermolecular contacts. It has
been postulated that these terminal helices are critical for
maintaining the trimeric assembly and protein-protein inter-
actions (14). Among these structural arrangements, the HA-
binding motif in each trimeric assembly is solvent-exposed. In
our previous report (18), we have shown that HABP1 exists
predominantly as a non-covalently linked trimer near physio-
logical conditions and as a hexamer (dimer of trimers) in the
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oxidative environment. The isoelectric point (pI) of HABP1 is
4.10, and there are more than average polar amino acid resi-
dues (43%) present in the molecule. In addition, asymmetric
charge distribution on the surface of HABP1 allows the pre-
dominance of electrostatic interactions in dictating its folding
topology and tertiary interactions.
The relative role of the contribution of electrostatic interac-
tions to protein stability, compared with that of hydrophobic
interactions, has been the subject of long-standing queries (19).
In the present study, we examine the physical stability, struc-
tural flexibility, and conformational diversity of HABP1 under
in vitro conditions as a function of ionic strength to provide a
rationale for the marginal stability at neutral pH and to ex-
plain its differential binding toward ligands.
EXPERIMENTAL PROCEDURES
Materials—EAH-Sepharose 4B, Superose-6 column, and low molec-
ular weight markers were obtained from Amersham Biosciences. All
other chemicals (unless otherwise mentioned) were obtained from
Sigma. For every purpose MilliQTM grade water was used.
Purification and Estimation of HABP and Preparation of Its Poly-
clonal Antibodies—Recombinant HABP1 (amino acids 74–282, with
Leu74 to Met74 substitution) was overexpressed in Escherichia coli as
described earlier (7). HABP1 was purified by a 65–90% ammonium
sulfate cut, followed by ion exchange chromatography on MonoQTM HR
10/10 column (Amersham Biosciences), interfaced with an FPLCTM
system (Amersham Biosciences) using a linear gradient of 0–1 M NaCl
in 20 mM HEPES, 1 mM EDTA, 1 mM EGTA, 5% glycerol, and 0.2%
2-mercaptoehanol, pH 7.5, followed by hyaluronan-Sepharose affinity
column chromatography with the modification of an earlier report (18).
Affinity-purified HABP1 was further purified by size exclusion chroma-
tography in 10 mM phosphate-buffered saline containing 150 mM NaCl
and 0.2% 2-mercaptoethanol. The antibodies against the purified re-
combinant HABP1 were raised in New Zealand White rabbit as re-
ported earlier (7).
For all practical purposes the concentration of a known aliquot was
determined in 20 mM phosphate buffer, pH 6.5, containing 6 M guani-
dinium HCl by measuring the absorbance at 280 nm at 25 °C on a
Cary100 Bio UV-visible double beam spectrophotometer (Varian Inc.,
Australia) interfaced with peltier thermal controller. The molar extinc-
tion coefficient of denatured HABP1 was calculated by the method
reported earlier (20) and was found to be 22,190 at 280 nm, which
corresponds to A0.1%  0.932.
Gel Permeation Chromatography—Gel permeation chromatography
of HABP1 was carried out on Superose 6TM (1  30 cm) analytical
column (Amersham Biosciences) interfaced with an FPLCTM system in
10 mM phosphate buffer, containing 0.1% 2-mercaptoethanol (v/v) and
varying concentrations of either NaCl or KCl, pH 7.2, at a flow rate of
0.3 ml/min. Typically 100 l of 1 mg/ml HABP1 in desired buffer was
injected in each case. The standard molecular weight markers of known
molecular weight and Stokes radius, e.g. alcohol dehydrogenase (150
kDa, 46 Å), bovine serum albumin (67 kDa, 35.5 Å), ovalbumin (43 kDa,
30.5 Å), chymotrypsinogen (25 kDa, 20.9 Å), and ribonuclease A (13.7
kDa, 16.4 Å), were independently run in different cases before and after
each run. Calculation of Stokes radius was done by the method reported
earlier (21, 22).
Covalent Cross-linking of HABP1 Subunits—To HABP1 (0.2 M) in
10 mM phosphate buffer, pH 7.2, containing varying amounts of NaCl
(0–1 M), an aliquot of 25% (mass/volume) glutaraldehyde was added so
as to make a final concentration ranging from 1 to 4% of glutaralde-
hyde. This sample was incubated at 25 °C for 10 min followed by
quenching of the cross-linking reaction by adding 30 mM of 2-mercap-
toethanol (23). After 20 min of incubation sodium deoxycholate stock
was added to the reaction mixture to a final concentration of 0.3% (w/v).
The pH of the reaction mixture (in 10 mM phosphate buffer containing
varying amounts of NaCl, pH 7.2) was lowered to 2.0–2.5 by addition of
concentrated orthophosphoric acid that resulted in the co-precipitation
of cross-linked HABP1 with sodium deoxycholate. After centrifugation
(13,000 g, 4 °C) the precipitate was re-dissolved in 0.1 M Tris/HCl, pH
8.0, 1% SDS, and 0.1% 2-mercaptoethanol and heated at 90–100 °C for
3 min in a water bath and analyzed by electrophoresis.
ANS Binding Assay—The ANS binding assay was performed as
reported earlier (24). Briefly, the reagent 1-anilinonaphthalene-8-sul-
fonate (ANS), dissolved in water, was added to the protein samples, in
10 mM phosphate buffer containing different amounts of NaCl, to a final
concentration of 5 M and incubated for 10 min at room temperature in
each case. ANS added samples of HABP1 were excited at 380 nm, and
the emission spectra were recorded from 390 to 690 nm.
Circular Dichroism Spectral Studies—All of the far-UV CD spectra of
HABP1 were recorded on a Jasco 715 spectropolarimeter in 10 mM
phosphate buffer containing different amounts of NaCl to achieve the
desired ionic strength from 250 to 190 nm at 10 °C. The samples were
prepared 4 h before recording the spectra in desired buffer and centri-
fuged for 20 min at 10,000  g prior to recording. A rectangular cuvette
of 2 mm path length was used throughout the experiment. The concen-
tration of protein was kept constant at 10 M. Data were recorded at a
scan speed of 50 nm/min with a response time of 1 s at a bandwidth of
1 nm, and data were accumulated at 0.1-nm step intervals. The buffer
base line was subtracted in each case. Estimation of secondary struc-
tural content was performed using the software supplied with the
instrument.
Fluorescence Measurement—All of the fluorescence measurements
were carried out on a Cary EclipseTM spectrofluorimeter (Varian Inc.
Australia) at 25 °C. The concentration of the protein (0.05 mg/ml) was
chosen so that the absorbance at 280 nm was always 0.1 to avoid any
inner filter effect. Prior to every run, buffers and samples were either
filtered through 0.22-Millipore membranes or centrifuged at 10,000
g at 4 °C for 15 min. The path length of 1 cm, excitation and emission
slit width of 2.5 and 5 nm, respectively, and photomultiplier voltage of
600 V were kept constant for all the fluorescence measurements. The
base-line correction was done with buffer alone prior to every run. For
intrinsic fluorescence measurements, samples containing same amount
of protein and varying amounts of NaCl were excited at 282 nm, and the
emission was recorded at 350 nm.
Iodide Quenching—0.05 mg/ml HABP1 in 10 mM phosphate buffer
with varying amounts of NaCl were incubated with 0–0.2 M potassium
iodide in the presence of 10 M sodium thiosulfate for 1 h at 25 °C,
excited at 295 nm, and the emission was recorded at 350 nm, and the
emission intensity was plotted against the quencher concentration.
N-(1-Anilinonaphthyl-4)maleimide (ANM) Labeling of HABP1 and
Its Fluorescence Measurement—N-(1-Anilinonaphthyl-4)maleimide was
covalently attached to the only cysteine (Cys186) present in HABP1 by
using the method of Ohyashiki et al. (25) with slight modifications.
Briefly, 1 mg/ml HABP1 in 10 mM phosphate buffer was treated with 10
mM dithiothreitol and dialyzed extensively against 10 mM Tris/H2SO4
buffer, pH 7.2, containing 50 M dithiothreitol. To this solution, 1 mM of
final concentration of ANM, dissolved in trace amount of acetone, was
added and incubated for 60 min at 25 °C. The reaction was stopped by
adding 10 mM of dithiothreitol and dialyzed against 10 mM phosphate
buffer containing different amounts of NaCl. The number of anilino-
naphthyl (AN) group was determined spectrophotometrically with a
millimolar extinction coefficient of 10.8 mM1 cm1 at 345 nm (24). The
labeling is found to be 0.96 mol of AN group per mol of HABP1 monomer
(considering the sequence-derived molecular mass of 23,801.1 Da for
HABP1). For monitoring the conformational change associated around
Cys186 the samples were excited at 350 nm, and the emission was
recorded at 460 nm. To examine the resonance energy transfer, samples
were excited at 295 nm, and the emission spectra were recorded from
310 to 510 nm with different amounts of NaCl added to 10 mM phos-
phate buffer, pH 7.2. Base-line correction was done with the buffer
alone in each case.
Limited Proteolysis—HABP1 (1 M) in 10 mM sodium phosphate
buffer, pH 7.2, was incubated with varying amounts of NaCl to achieve
the desired ionic strength for 2 h at 25 °C followed by incubation with
trypsin (protease/HABP1 ratio 1:100 w/w) for 2 h at 25 °C in a 200-l
reaction volume. At higher salt concentrations the protease enzyme
ratio was increased so as to compensate for the loss of enzyme activity
as a result of the increase in ionic strength as described earlier (26). The
proteolysis was stopped using soybean trypsin inhibitor (Invitrogen) by
adding 1:2 w/w enzyme inhibitor ratio (26). 200 l of this digest was
injected in high resolution Sephacryl S200TM (16:60) pre-packed column
interfaced with AKTATM Basic (Amersham Biosciences) pre-equili-
brated with 10 mM phosphate buffer containing 150 mM of NaCl at a
elution rate of 0.8 ml/min. The elution was monitored at 225 nm.
Ligand Binding Assays—Microtiter plate-binding assays were car-
ried out to investigate the effect of ionic strength on the interactions of
HA, DMA, and C1q with HABP1. The assays, which are based on those
described previously (27–28), determine colorimetrically the level of
binding of HABP1 to wells coated with HA, c1q, or DMA. All dilutions
and incubations were performed in standard assay buffer (SAB, 10 mM
phosphate buffer, pH 7.2) containing varying amounts of NaCl to
achieve the desired ionic strength at room temperature. All washes
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were performed in SAB containing 150 mM NaCl and 0.05% (v/v) Tween
20. Plastic Costar flat bottomed and high binding microtiter plates
(EIA/RIA) were coated (in triplicate) overnight with 100 l/well of 10
g/ml HA and DMA, prepared as described earlier (29), and c1q in 20
mM carbonate buffer (Na2CO3-NaHCO3), pH 9.6, at 4 °C. Control wells
were treated with buffer alone. The coating solution was removed, and
the plates were washed three times, and nonspecific binding sites were
blocked by incubation with 1.5% (w/v) bovine serum albumin for 90 min
at 37 °C, followed by three washes. Finally, the respective wells were
rinsed three times with SAB containing different amounts of salt. 100
l of 50 g/ml HABP1 in 10 mM sodium phosphate buffer containing
different amounts of NaCl was added to each well and incubated for 4 h
at room temperature or overnight at 4 °C. Plates were washed three
times, and 100 l of a 1:5000 dilution of polyclonal anti-HABP1 anti-
bodies (in SAB) was added and incubated for 90 min, followed by five
washes. 100 l/well of a 1:30,000 dilution of horseradish peroxidase-
conjugated goat anti-rabbit IgG in SAB was added to each well and
incubated for 1 h at room temperature. The secondary antibodies were
sipped out of the wells and washed five times and finally rinsed with
substrate buffer (100 mM phosphate-citrate buffer, pH 5.0). 100 l of 0.6
mg/ml solution of 2,2-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)
(ABTS) in substrate buffer containing 3 l of H2O2/ml of buffer was
added to each well and incubated for 10 min at 37 °C for color develop-
ment. For competitive binding assays, 100 l/well of 10 g/ml of DMA
was coated on microtiter plates and incubated with 100 l of 1 g/ml of
biotinylated HABP1 in 10 mM phosphate buffer containing different
amounts of salt, pH 7.2, which was preincubated with varying amounts
of unlabeled HA, DMA, or C1q. The bound HABP1 was detected by
1:30,000 dilution of ExtrAvidin-horseradish peroxidase conjugate using
ABTS as a substrate. Absorbance at 405 nm was determined on a
microtiter plate reader (Bio-Rad model 550 microplate reader). All
absorbances were corrected against blank wells. Each data point is the
average of three similar sets of experiments. For absolute binding
absorbance at 405 nm was plotted against the increasing salt concen-
trations, and for competitive binding assays the percentage inhibition
was plotted against increasing concentrations of unlabeled ligands at
different salt concentrations.
RESULTS
Decreased Hydrodynamic Volume of Trimeric HABP1 with
Increasing Ionic Strength—In order to identify the oligomeric
state of the molecule under the reducing conditions as a func-
tion of salt, covalent cross-linking of the oligomeric subunit was
performed under the conditions of different ionic strength used
throughout the experiment. The peak fractions of the protein
eluted as a function of ionic strength on Superose 6 HR 10/30
column were cross-linked using 2% glutaraldehyde and exam-
ined on SDS-PAGE (Fig. 1A). The data showed that HABP1
exists predominantly as trimer in equilibrium with a small
proportion of monomer in the absence of salt (Fig. 1A). The
relative band intensities of the cross-linked product in the
absence of salt indicate that this equilibrium is biased in the
FIG. 1. Salt-induced changes in hydrodynamic properties of trimeric HABP1. A, covalent cross-linking of HABP1 subunit using 2%
glutaraldehyde. 0.1 mg/ml HABP1 in 10 mM phosphate buffer, pH 7.2, incubated with different amounts of NaCl, shown on the top of the lane, was
cross-linked using glutaraldehyde as described under “Experimental Procedures” and separated on 12.5% SDS-PAGE and stained with Coomassie
Brilliant Blue R-250. Molecular mass markers are shown on the right margin. B, size exclusion chromatographic profiles of HABP1. 100 l of 1
mg/ml HABP1 in 10 mM phosphate, pH 7.2, at different ionic strengths were injected on Superose 6 HR30 analytical column at an elution speed
of 0.3 ml/min, and absorbance at 280 nm was plotted against elution volume. The ionic strength was achieved by adding required amount of NaCl
to keep the molarity of phosphate and pH constant. The mean elution volumes of standard molecular mass markers of different Stokes radii are
as follows: arrow 1, alcohol dehydrogenase (150 kDa, 46 Å); arrow 2, bovine serum albumin (67 kDa, 35.5 Å); arrow 3, ovalbumin (43 kDa, 30.5 Å);
arrow 4, chymotrypsinogen (25 kDa, 20.9 Å); and arrow 5, ribonuclease A (13.7 kDa, 16.4 Å). The base line is translated upward for the clarity of
data. C, hydrodynamic radius of HABP1. The change in the Stokes radius with increasing NaCl (open circle) and KCl (solid circle) concentration,
calculated by taking the mean elution volume of each peak as described under “Experimental Procedures” and plotted against the ionic strength
of the buffer. The standard deviation (n  3) is shown as () error bars on each data point.
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favor of trimer. However, this protein exists only as a trimer in
the presence of salt as low as 10 mM.
In order to examine if electrostatic repulsion in HABP1, an
acidic protein, is indeed responsible for expanded structure in
low ionic environment, size exclusion chromatography was car-
ried out in 10 mM phosphate buffer, pH 7.2, containing 0.1%
2-mercaptoethanol with varying concentrations of NaCl 0.01–1
M (Fig. 1B). The elution peak at low ionic strength (0.01 M) is
broad and diffused as against the peaks at higher ionic
strengths, which are relatively sharp. The broad diffused na-
ture of the peak under low ionic strength is perhaps due to the
interactions of the gel filtration medium with the conforma-
tional ensemble of HABP1 that includes variations from the
crystallographically observed compact structure. A gradual in-
crease in elution volume (Ve) was observed with increasing salt
concentrations, which reflects a gradual decrease in the hydro-
dynamic volume (Vh) of the molecule. Therefore size exclusion
chromatographic data were further analyzed for calculating
the hydrodynamic size of the molecule by comparing with the
standard molecular weight markers of known Stokes radii as
described earlier and plotted against the ionic strength (Fig.
1C, open circles). To see any cation specificity, a similar set of
experiments was carried out in the presence of KCl, and the
Stokes radius was plotted against the increasing concentration
as shown in Fig. 1C (solid circles). The changes in cation-
induced structural compaction did not suggest any specific ion
selectivity. The important observations of our study are con-
cerned with strikingly different state of compactness, induced
by increasing amounts of salt in the molecular environment.
For example, the loosely held trimers in the absence of salt
were so expanded that they eluted much earlier than the com-
pact trimer under the conditions involving 150 mM to 1 M
NaCl/KCl. As the ionic strength is increased, there is a gradual
increase in the compactness of trimer such that the compact
form of the trimer has a Stokes radius of 36.9 Å at 150 mM and
31 Å at 1 M salt concentration (Fig. 1C) as compared with the
most expanded trimer, which has a Stokes radii of 42 Å. There-
fore, the broad peak corresponding to a Stokes radius of nearly
42 Å is apparently not due to any higher order oligomer be-
cause the whole experiment is conducted under reducing con-
ditions, and the subsequent cross-linking experiment failed to
identify any higher oligomer. To assess further the oligomeric
distribution of HABP1 at higher salt concentrations, cross-
linking as a function of glutaraldehyde was performed, and no
detectable oligomer other than trimer was observed until 4% of
glutaraldehyde at these salt concentrations (data not shown).
Thus our results suggest that HABP1 exists as a loosely held
expanded trimer in low ionic environments, which undergoes
structural compaction with increasing ionic strength.
Existence of Expanded Trimeric HABP1 as a Molten Globule-
like State in Low Ionic Environment—The presence of an ex-
panded structure of trimeric HABP1 may result in the expo-
sure of the hydrophobic core similar to the molten globule-like
state of the molecule, if any. To investigate any such possibility
in the case of HABP1, hydrophobic reporter dye, 1,10-anilinon-
aphthylsulfonate, binding was carried out at different ionic
strengths. ANS is a weak fluorescent molecule when free. How-
ever, the fluorescence emission intensity increases with a char-
acteristic blue shift in emission maximum when it is bound to
the hydrophobic core of the protein (24). ANS binding was
observed from enhancement of the emission intensity with a
blue shift of nearly 50 nm with respect to free ANS under low
ionic strength where protein exists predominantly as a loosely
held trimer in dynamic equilibrium with a very small propor-
tion of monomer (Fig. 2). Our observations on the significant
increase of ANS binding suggests that the expanded trimer is
somewhat similar to a molten globule-like state under low ionic
environments. With an increase in ionic strength HABP1 folds
appropriately into a stable conformation so that the hydropho-
bic core is inaccessible for ANS binding.
Effect of Ionic Strength on the Structural Properties of
HABP1—To probe the ionic environment-mediated structural
changes of HABP1 from expanded molten globule-like state to
a compact stable folded form, spectroscopic investigations (far-
UV CD, intrinsic as well as extrinsic fluorescence, fluorescence
quenching, and fluorescence resonance energy transfer exper-
iments) were carried out as a function of ionic strength.
To probe the structural changes in trimeric HABP1 as a
FIG. 2. Existence of molten globule-like state of HABP1 at low
ionic strength. 0.05 mg/ml HABP1 in 10 mM phosphate buffer, pH 7.2,
containing different amounts of NaCl at 25 °C was treated with a 5 M
final concentration of ANS and excited at 380 nm, and the emission
spectra were recorded. The various curves represent the emission spec-
tra in the presence of various amount of salt: 0 (curve 1), 20 (curve 2), 50
(curve 3), 150 (curve 4), 300 (curve 5), and 600 mM (curve 6). Blank
(buffer alone) was run separately in each case and subtracted from the
sample spectra under similar conditions.
FIG. 3. Effect of ionic strength on secondary structure of
HABP1. Far-UV CD spectra of HABP1 (10 M) in 10 mM sodium
phosphate buffer containing different amounts of salt. The various
curves are the CD spectra of HABP1 in 0 (curve 1), 150 (curve 2), and
600 mM (curve 3), and 1 M (curve 4) of NaCl concentration.
Structural Flexibility of HABP1/p32/gC1qR 27467
 by guest, on Septem
ber 24, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
function of ionic strength, its secondary structural content was
investigated by far-UV circular dichroism spectroscopy. The
spectra were recorded in 10 mM phosphate buffer, pH 7.2, at
different ionic strength conditions using sodium chloride (0–1
M) and are presented in Fig. 3 after subtracting the buffer base
line. The minima in the absence of salt lies at 205 nm, although
it gives a double minima at 219.3 and 210 nm at higher salt
concentrations (150 mM to 1 M, curves 2–4, Fig. 3) with nearly
four times increase in molar ellipticity, indicating a shift to-
ward more rigid and ordered structure. The secondary struc-
tural content of the molecule increases with increasing salt
concentrations. Moreover, the percentage compositions of var-
ious secondary structural elements derived from our data un-
der 600 mM of salt are in fair agreement with the crystal
structure determined under almost similar conditions. How-
ever, in the absence of salt or at very low salt concentrations,
the molecule tends to show loss in secondary structure.
In order to examine further the effect of ionic strength on the
FIG. 4. Salt-induced conformational change in HABP1. A, intrinsic fluorescence measurement HABP1 (0.05 mg/ml) in 10 mM phosphate
buffer, pH 7.2, at different ionic strength were excited at 282 nm, and emissions were recorded at 350 nm, blanks (buffer alone) were recorded prior
to sample recording and subtracted from the sample and plotted against the salt concentration. B, iodide quenching of intrinsic fluorescence. 0.05
mg/ml of HABP1 was treated with different amounts (0–0.2 M) of KI with 10 M sodium thiosulfate in 10 mM phosphate buffer containing the
following: , 10;, 50; , 150; E, 600; and  1000 mM of NaCl and excited at 295 nm. The emission was recorded at 350 nm. Emission intensity
in the absence of KI is taken to be I0 in each case and I0/I 1 was plotted against quencher concentration. C, extrinsic fluorescence measurements.
The only cysteine in each HABP1 molecule was covalently tagged with N-(1-Anilinonaphthyl-4)maleimide as described under “Experimental
Procedures” and excited at 350 nm, and emission was recorded at 460 nm. The change in fluorescence emission intensity of ANM-tagged cysteine
was plotted against increasing salt concentrations. D, change in average distance between cysteine (Cys186) and tryptophans in HABP1. The only
cysteine (Cys186) present in HABP1 was covalently tagged with N-(1-Anilinonaphthyl-4)maleimide (ANM), and 0.05 mg/ml of the modified protein
in 10 mM phosphate buffer containing 1 M (curve 1), and 600 (curve 2), 300 (curve 3), 150 (curve 4), and 50 mM (curve 5) and in the absence of salt
(curve 6) were excited at 295 nm, and emission were recorded from 310 to 510 nm.
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local structure around tryptophan and cysteine in HABP1,
intrinsic as well as extrinsic fluorescence and fluorescence res-
onance energy transfer experiments were carried out under
different conditions of ionic strength.
HABP1 has three Trp residues spread all over the molecule
(Trp109, Trp219, and Trp233) with almost symmetrical microen-
vironment as calculated from the crystal structure. Intrinsic
fluorescence studies were carried out to probe the relative
change in fluorescence emission intensity as a function of in-
creasing salt concentration. Samples were excited at 282 nm,
and the emission was recorded at 350 nm. A gradual decrease
in the tryptophan intensity was observed at 350 nm (Fig. 4A).
The data suggest that the solvent accessibility of the three
tryptophans together is reduced due to salt-induced structural
compactness.
The exposure of tryptophan was also investigated by iodide
quenching studies as described under “Experimental Proce-
dures.” Fluorescence emission intensities were corrected for
any dilution effects and for iodide absorbance (if any) at the
excitation wavelength. Fluorescence quenching data were an-
alyzed according to the general form of the Stern-Volmer Equa-
tion 1 (30),
I0/I 1KSVQ	
 (Eq. 1)
where I0 and I are the fluorescence intensities in the absence
and presence of quencher, respectively; KSV is Stern-Volmer
quenching constant, and [Q] is the total quencher concentra-
tion. The data on the gradual decrease in KSV with increasing
salt concentrations support the intrinsic fluorescence studies
on gradual inaccessibility of tryptophan residues to the solvent
with increasing salt concentrations (Fig. 4B).
To assess further whether the local structural changes are
indeed real, an extrinsic probe ANMwas covalently attached to
the only cysteine (Cys186) present in each HABP1 molecule and
was confirmed by spectrophotometry as described under “Ex-
perimental Procedures.” It has been reported earlier that free
ANM is non-fluorescent but becomes fluorescent when co-
valently attached to cysteine (24). The emission intensity of the
AN group depends on the microenvironment around it. To
investigate the solvent exposure of cysteine as a function of salt
concentration, the AN group tagged HABP1 was excited at 350
nm, and the fluorescence emission intensity was recorded at
460 nm. The change in emission intensity as a function of salt
was plotted and is presented in Fig. 4C. Interestingly, a grad-
ual decrease in the fluorescence emission intensity was ob-
served with increasing salt concentrations. The data suggest
that the cysteine residue has a differential degree of exposure
at different ionic strengths.
To examine any change in the average distance between
cysteine and tryptophans, fluorescence resonance energy
transfer measurements were carried out under similar sets of
ionic strengths. Interestingly, the emission maximum of tryp-
tophan falls in the range of the excitation maximum for the AN
group attached to cysteine. This very aspect of AN group fluo-
rescence was used to see the FRET efficiency of tryptophan as
a function of ionic strength of the buffer. There is a gradual
increase in the emission intensity of the AN group tagged to
cysteine at 455 nm with a simultaneous decrease in emission
peak intensity of tryptophan increasing salt concentration un-
til 1 M implying an overall change in the average distance
between tryptophans and cysteines (Fig. 4D). Such decrease in
average distance between tryptophans and cysteines in the
HABP1 trimer indicates the conformational changes associated
with the molecule upon structural compaction.
Evidence for Salt-mediated Structural Compactness of
HABP1 by Limited Proteolysis—The factors determining the
vulnerability for proteolysis of a protein by protease depends on
the conformational parameters such as accessibility, segmental
motion structural compactness, and protrusions. Due to this
reason, limited proteolysis has been effectively used to monitor
protein surface regions and the solution conformation of the
molecule (31). The proteolytic susceptibility of HABP1 to tryp-
sin at 0, 150, and 1 M of salt concentration was analyzed. To
compensate any loss of trypsin activity due to increasing ionic
strength, enzyme concentration was increased in the same
ratio of its decrease as reported earlier (26). There are 21 lysine
and arginine residues spread all over the HABP1 molecule, and
hence an extensive proteolysis is expected resulting in a num-
ber of smaller peptide fragments if the protein exists in an
expanded conformation. Indeed, at low salt concentrations,
where HABP1 seems to exist in an ensemble of expanded
conformations, a number of smaller peptide fragments gener-
ated as is evident from the peaks corresponding to lower mo-
lecular size on the chromatographic profile of limited trypsin
digestion in the absence of salt (Fig. 5). However, at higher salt
concentrations (0.15 and 1 M), HABP1 seems relatively resist-
ant toward tryptic digestion compared with that in the absence
of salt, as is apparent from the appearance of undigested frac-
tions at 150 mM and beyond. In addition, the peptide fragment
of larger size is also detected. Thus, it is logical to conclude that
the increased ionic strength leads to inaccessibility of the sites
susceptible for protease attack in HABP1, presumably due to
enhanced compactness of structure.
Ionic Strength Affects the Ligand Binding of HABP1—In
order to examine whether this salt-induced structural transi-
tion can regulate the affinity of multifunctional HABP1 toward
different ligands, HA, C1q, and DMA, binding assays were
performed as a function of increasing salt concentrations as
described under “Experimental Procedures.” The data demon-
strate that there is no binding of HABP1 with HA in absence of
salt (Fig. 6A); however, the other two ligands, c1q and DMA,
show substantial binding under these experimental conditions.
FIG. 5. Change in protease susceptibility of HABP1 with in-
creasing ionic strength. HABP1 (1 M) in 10 mM sodium phosphate
buffer was treated with different amounts of NaCl and subjected to
limited proteolysis with trypsin as described under “Experimental Pro-
cedures.” The trypsin digestions were stopped by adding 1:2 (w/w) of
soybean trypsin inhibitor and injected on Sephacryl S200 (16/60) pre-
packed column, and the elution volume was plotted against the absorp-
tion at 225 nm. The arrows show the mean elution volume of trypsin
and soybean trypsin inhibitor run independently on the same column
under similar conditions. y axis is translated upward for the clarity of
data.
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There is a gradual increase in HA binding with increasing salt
concentrations with maximum binding at around 150 mM
NaCl, although such significant changes with the other two
ligands were not observed. Beyond 150 mM salt concentrations,
a gradual decrease in the binding was observed, which abol-
ished completely above 600 mM ionic strength with all the
ligands. Thus, a threshold amount of salt is needed for opti-
mumHA-HABP1 interaction; however, the same is not the case
with other two ligands. At higher salt concentrations, the bind-
ing is abolished due to various factors including hydrophobic as
well as electrostatic interactions, which seem important regu-
lators for the affinity of HABP1, as is the case with several
other HA-binding proteins. When DMA-coated wells were as-
sayed with biotinylated HABP1 preincubated with increasing
concentrations of unlabeled DMA, HA, or C1q at two extremes
of salt concentration, it was observed that at 10 mM of NaCl
neither HA nor C1q inhibited HABP1 binding to DMA (Fig. 6B,
i). However, at higher salt concentrations the inhibition was
observed in a dose-dependent manner with HA only (Fig. 6B,
ii). Preincubation with C1q did not affect the HABP1 binding to
DMA, suggesting the fact that C1q and DMA/HA-binding sites
on HABP1 are exclusive, and they seems to behave independ-
ently. The data at two extremes of salt suggest that DMA and
HAmay share an overlapping binding site on HABP1; however,
their modes of binding are different. Furthermore it is clear
from these studies that a minimum three-dimensional rigid
structure is needed for any optimum HA-HABP1 interactions,
which is not the case with the other two ligands.
DISCUSSION
Recently we have reported that HABP1, a multifunctional
protein, exists in different oligomeric forms under various in
vitro conditions in solution, although the molecule is predomi-
nantly trimeric in anaerobic conditions at 150 mM salt concen-
tration (18). HABP1, having an HA-binding motif (Lys119–
Lys128), is reported to bind with HA with a Kd of 1.1  10
9,
with C1q through the first 24 residues on the NH2 terminus
with a nanomolar dissociation constant (13), and with clustered
mannose (29). We were interested in probing its structural
behavior under different in vitro conditions to address some of
its intriguing behaviors. Thus, we have examined the struc-
tural plasticity of HABP1 under various in vitro conditions as a
function of ionic strength, and we tried to correlate the inher-
ent structural flexibility with its binding toward different li-
gands. Here we provide the experimental evidence for struc-
tural transitions of HABP1 induced by the ionic environment
around the molecule, which has a direct implication on HA
binding compared with the other two ligands.
Existence of Molten Globule-like State of Trimeric HABP1 in
Low Ionic Environment—It is evident from several independ-
ent experiments, using diverse techniques, that HABP1 exists
in a highly expanded structure under low ionic strength. The
hydrodynamic volume (Vh) of the molecule in the presence of 10
mM of salt at neutral pH is nearly 1.5 times that in presence of
1 M of salt (Fig. 1B). Extensive digestion of HABP1 in the
absence of salt into smaller fragments by trypsin also suggests
the existence of an expanded structure under such conditions
where sites for protease attack are highly accessible (31). Cir-
cular dichroism profile in the absence of salt shows a minimum
at 205 nm which changes to a double minima at 210 and
220 nm, typical of    class of proteins suggesting the
FIG. 6. Regulation of HABP1 interactions with different li-
gands by ionic strength. A, differential binding of HABP1 toward
different ligands at varying ionic strength. Different ligands of HABP1
(circle), HA (down triangle), and C1q (up triangle) mannosylated albu-
min were coated in 96-well enzyme-linked immunosorbent assay plate
as described under “Experimental Procedures” and incubated with
HABP1 in 10 mM phosphate buffer containing different amount of salt
and probed with 1:5000 dilution of anti-HABP1 antibodies and devel-
oped with 1:10,000 dilution of horseradish peroxidase-conjugated goat
anti-rabbit IgG using ABTS as substrate. Bound HABP1 per g of
different ligand was plotted against the ionic strength. B, effect of ionic
strength on the competition of DMA to HABP1 by other ligands. DMA-
coated wells were incubated with biotinylated HABP1, preincubated
with varying concentrations of unlabeled HA (circle), DMA (square),
and C1q (triangle) in the presence of 10 mM (i) and 300 mM (ii) of NaCl,
and bound HABP1 was detected. Blank wells were coated with buffer
alone and were subtracted from the sample wells. Percentage of bound
HABP1 was plotted against increasing concentration of ligands. The
standard deviation (n  3) is shown as error bars on each data point.
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existence of disordered structure of HABP1 under low ionic
strength, which changes to more ordered structure with in-
creasing ionic strength. The efficiency of FRET is minimum in
the buffers of low ionic strength suggesting the large distance
of Cys186 from the tryptophans (Fig. 4D). Hydrophobic reporter
dye, ANS, binding was found maximum in low ionic environ-
ment (Fig. 2). This suggests that the expanded structure of
HABP1 may be similar to molten globule-like state under low
ionic environment, which is in agreement with several recent
reports (32). All experimental evidence suggests that at a low
ionic environment HABP1 exists in an expanded molten glob-
ule-like state, which attains a globular conformation above 50
mM of salt concentrations. Our observations are in agreement
with the recent reports (32–35) of salt-mediated disorder-order
transition of several other highly acidic proteins similar to
HABP1.
Transitions from Expanded to Compact Trimer with Increas-
ing Ionic Strength—The gradual increase in ionic strength (150
mM to 1 M) results in a simultaneous decrease in shape and size
of the molecule with increased secondary structural content. It
is concluded on the basis of several independent experiments
demonstrating the decrease in hydrodynamic volume (Vh), in-
trinsic tryptophan fluorescence, extrinsic fluorescence emission
intensity of anilinonaphthyl group tagged at Cys186, complete
abolition of ANS binding above 50 mM salt concentration, and
increased FRET efficiency of the molecule. Neutralization of
charges on HABP1 by counter ions seems to promote the tran-
sition from disordered to ordered structure, which is in agree-
ment with recent reports (34–36).
This global change in the shape of the molecule seems to
originate from the different conformations that the molecule
adapts under the influence of changes in ionic strength. Our
observations of the gradual decrease in the intrinsic as well as
extrinsic fluorescence intensities suggest that the salt-induced
changes in hydrodynamic volume of the molecule leads to the
conformational change of the molecule. A gradual change in
tryptophan fluorescence emission intensity results from the
gradual inaccessibility of the indole ring to the solvent. This
interpretation is strengthened by the fact that iodide, a polar
fluorescence quencher, quenches fluorescence emission inten-
sity at much faster rate in the buffer of low ionic strength than
that of high ionic strength. Solvent accessibility of cysteine also
seems to be affected by the ionic strength of the environment
around the molecule, which is consistent with the earlier ob-
servations (18) where trimeric HABP1 is shown to dimerize
through the only cysteine present in each molecule under oxi-
dative conditions.
Structural Plasticity of HABP1 Regulates Its Binding toward
Different Ligands—HABP1 is an acidic protein (pI 4.1) with
low intrinsic hydrophobicity and high net charge at neutral pH.
The trimeric HABP1 has a charge of81 at pH 7.2. Most of the
negative charges are present on one surface including the inner
wall of the propeller-like channel of the molecule (14). This
surface charge localization may allow the electrostatic repul-
sion to take predominance over other interactions in dictating
the folding topology and three-dimensional structure. The
asymmetric charge distribution along the faces of HABP1 may
force the molecule to exist in marginally stable, expanded con-
formations at 10–25 mM ionic strength (37). This marginally
stable expanded conformation attains a compact stable struc-
ture at 150–600 mM, which further becomes more compact at
higher salt concentration (600 mM to 1 M).
The structural plasticity of HABP1 may play an important
role in regulating its binding toward different ligands. Under
the conditions of 10 mM ionic strength, where HABP1 exists in
a loosely held trimeric structure, it fails to bind HA. However,
it shows appreciable binding with other reported ligands/inter-
acting molecules, namely C1q and clustered mannose (Fig. 6A).
This fact suggests that binding of HABP1 toward different
ligands is governed by its structural state. The binding of
HABP1 toward HA shows a drastic change from 0 mM of NaCl
(no binding) to 20 mM of NaCl (substantial binding), where
HABP1 gains structure to some extent. Further increase in HA
binding with increasing salt concentration up to 150 mM sug-
gests the improvement of binding due to the better structural
fit of the HABP1 for its ligand HA. Other ligands do not show
any significant change in binding levels under a similar set of
conditions. Salt-induced structural variations of HABP1 affect
hyaluronan binding and the binding of two other ligands to
loosely held trimeric HABP1 and facilitated interesting in-
sights into the nature of the binding sites on HABP1 for three
different ligands. C1q does not show any appreciable inhibition
of DMA binding at any ionic strength, although it can bind with
the loosely held (at 10 mM) as well as compact (at 300 mM)
trimeric HABP1. Our data suggest that C1q, which binds at
NH2-terminal region of HABP1, remains unaffected with DMA
binding. It is apparent that C1q-binding site on HABP1 is
independent of DMA/HA-binding sites, and its nature of bind-
ing is also different. Our data on the competitive inhibition of
HABP1 binding to DMA by HA only at higher ionic strength
where HA can bind to HABP1 suggests that HA and DMA
share an overlapping binding site on HABP1. However, at low
ionic strength, where HA does not bind to HABP1, it fails to
inhibit the HABP1-DMA binding, implying that the nature of
binding of HA and DMA are different. Thus, it appears logical
to argue that a minimum rigid three-dimensional structure
apart from the presence of BX7B (where B stands for any basic
and X for any non-acidic amino acid residues) motif is essential
for any relevant HA-HABP1 affinity, which is recently pro-
posed by Day and Prestwich (2). The salt-induced effects on the
structure and stability of HABP1 are attributed to the binding
of counter ions, resulting in minimization of intramolecular
electrostatic repulsion. This leads to increased stability and
greater compactness in the structure, as observed. Conse-
quently, localized electrostatic repulsion is present at neutral
pH in HABP1, probably contributing to expanded molten glob-
ule-like structure and its marginal stability.
The transitions from loosely held trimeric structure to com-
pact ordered structure might be linked with one of its reported
functions as a molecular chaperon. HABP1 is known to regu-
late the kinase activity of almost all isoforms of protein kinase
C at 50 mM ionic strength under reducing conditions without
being their substrate like a molecular chaperon (38–39). In this
context these structural transitions are important because of
the fact that the accessible hydrophobic surface is the key
element for chaperon-like action (40). It is important to men-
tion that our observation demonstrates that the hydrophobic
surface remains accessible at 50 mM ionic strength supporting
its molecular chaperon-like activity demonstrated with protein
kinase C (39). These accessible surfaces can be perturbed by
the change in the ionic strength in the microenvironment of the
molecule (41). Finally, it may be noted that HABP1 may belong
to the group of eukaryote proteins, which remain only partially
structured under physiological conditions and execute numer-
ous functions consistent with the physico-chemical microenvi-
ronment of the molecule.
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